Clinical Trial Update: Effect of All-trans Retinoic Acid With Chemotherapy Based in Paclitaxel and Cisplatin as First Line Treatment of Patients With Advanced Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating all-trans retinoic acid in combination with paclitaxel and cisplatin as first-line therapy for advanced non-small cell lung cancer; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• All-trans Retinoic Acid (all-trans retinoic acid)
• CISPLATIN (cisplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: National Institute of Cancerología | Conditions: Non-Small-Cell Lung Carcinoma | Phase 2 | Status: COMPLETED